Aligos Therapeutics Inc. (ALGS) NASDAQ

$1.31 -0.04 (-2.96%)

Market Cap: $57.64M

As of 06/28/22 03:55 PM EDT. Market closed.

(ALGS)

Aligos Therapeutics Inc. (ALGS) NASDAQ

$1.31 -0.04 (-2.96%)

Market Cap: $57.64M

As of 06/28/22 03:55 PM EDT. Market closed.

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted ... read more

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
80
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$1.35
Previous Close
$1.35
Days Range
$1.21 - $1.42
52 week range
$1.03 - $22.05
Volume
80,685
Avg. Volume (30 days)
355,501
Market Cap
$57.64M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
42,695,195
Open
$1.35
Previous Close
$1.35
Days Range
$1.21 - $1.42
52 week range
$1.03 - $22.05
Volume
80,685
Avg. Volume (30 days)
355,501
Market Cap
$57.64M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
42,695,195

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALIGOS THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Novo Holdings A/S 10% Owner Oct 20, 2020 Buy $15.00 200,000 3,000,000 2,614,563 Oct 22, 2020, 04:31 PM
Woiwode Thomas Director Oct 20, 2020 Buy $15.00 200,000 3,000,000 862,444 Oct 20, 2020, 05:00 PM
Vivo Capital VIII, LLC 10% Owner Oct 20, 2020 Buy $15.00 66,733 1,000,995 430,372 Oct 20, 2020, 04:59 PM
Vivo Capital VIII, LLC 10% Owner Oct 20, 2020 Buy $15.00 483,267 7,249,005 3,116,658 Oct 20, 2020, 04:59 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 20, 2020 Buy $15.00 200,000 3,000,000 862,444 Oct 20, 2020, 04:58 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
Novo Holdings A/S 10% Owner 10/20/2020 3,000,000
Woiwode Thomas Director 10/20/2020 3,000,000
Vivo Capital VIII, LLC 10% Owner 10/20/2020 1,000,995
Vivo Capital VIII, LLC 10% Owner 10/20/2020 7,249,005
Versant Venture Capital VI, L.P. 10% Owner 10/20/2020 3,000,000
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
09/30/2021
8.58%
2Q
03/31/2022
06/30/2021
13.28%
3Q
03/31/2022
03/31/2021
13.56%
4Q

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
8.58%
2Q
06/30/2021
13.28%
3Q
03/31/2021
13.56%
4Q